Advertisement

Surgery pp 2325-2344 | Cite as

Injectable Biomaterials in Surgery

  • Bilal Shafi
  • Carlos Mery
  • Gary Binyamin
  • Joseph Knight
  • Michael E. Gertner

Abstract

Biomaterials in clinical practice encompass an enormous breadth of different materials, performing varied functions and taking different forms. Injected biomaterials are a unique subset within the biomaterial field, really entering the mainstream in recent years with the proliferation of minimally invasive technologies. Undoubtedly, as the breadth and depth of minimally invasive technology continues to grow, there will be a continued and even growing emphasis on newer materials or in some cases adaptation of older materials for novel applications.

Keywords

Hyaluronic Acid Fibrin Glue Fibrin Sealant Vertebral Compression Fracture Aneurysmal Bone Cyst 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bauer TW, Muschler GF. Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000;371:10–27.PubMedCrossRefGoogle Scholar
  2. 2.
    Charnley J. Anchorage of the femoral head prosthesis to the shaft of the femur. J Bone Joint Surg Br 1960;42B:28–30.Google Scholar
  3. 3.
    Kuehn KD, Ege W, Gopp U. Acrylic bone cements: composition and properties. Orthop Clin N Am 2005;36(1):17–28, v.CrossRefGoogle Scholar
  4. 4.
    Kuehn KD, Ege W, Gopp U. Acrylic bone cements: mechanical and physical properties. Orthop Clin N Am 2005;36(1):29–39, v–vi.CrossRefGoogle Scholar
  5. 5.
    Muhr G, Tscherne H, Thomas R. Comminuted trochanteric femoral fractures in geriatric patients: the results of 231 cases treated with internal fixation and acrylic cement. Clin Orthop Relat Res 1979;138:41–44.PubMedGoogle Scholar
  6. 6.
    Bartucci EJ, Gonzalez MH, Cooperman DR, Freedberg HI, Barmada R, Laros GS. The effect of adjunctive methylmethacrylate on failures of fixation and function in patients with intertrochanteric fractures and osteoporosis. J Bone Joint Surg Am 1985;67(7):1094–1107.PubMedGoogle Scholar
  7. 7.
    Schmalholz A. Bone cement for redislocated Colles’ fracture. A prospective comparison with closed treatment. Acta Orthop Scand 1989;60(2):212–217.PubMedGoogle Scholar
  8. 8.
    Schmalholz A. External skeletal fixation versus cement fixation in the treatment of redislocated Colles’ fracture. Clin Orthop Relat Res 1990;254:236–241.PubMedGoogle Scholar
  9. 9.
    Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE. The type of cement and failure of total hip replacements. J Bone Joint Surg Br 2002;84(6):832–838.PubMedCrossRefGoogle Scholar
  10. 10.
    Engesaeter LB, Lie SA, Espehaug B, Furnes O, Vollset SE, Havelin LI. Antibiotic prophylaxis in total hip arthroplasty: effects of antibiotic prophylaxis systemically and in bone cement on the revision rate of 22,170 primary hip replacements followed 0–14 years in the Norwegian Arthroplasty Register. Acta Orthop Scand 2003;74(6):644–651.PubMedCrossRefGoogle Scholar
  11. 11.
    Deramond H, Depriester C, Galibert P, Le Gars D. Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications, and results. Radiol Clin N Am 1998;36(3):533–546.PubMedCrossRefGoogle Scholar
  12. 12.
    Lieberman IH, Dudeney S, Reinhardt MK, Bell G. Initial outcome and efficacy of “kyphoplasty” in the treatment of painful osteoporotic vertebral compression fractures. Spine 2001;26(14):1631–1638.PubMedCrossRefGoogle Scholar
  13. 13.
    Berlemann U, Franz T, Orler R, Heini PF. Kyphoplasty for treatment of osteoporotic vertebral fractures: a prospective non-randomized study. Eur Spine J 2004;13(6):496–501.PubMedCrossRefGoogle Scholar
  14. 14.
    Diamond TH, Champion B, Clark WA. Management of acute osteoporotic vertebral fractures: a nonrandomized trial comparing percutaneous vertebroplasty with conservative therapy. Am J Med 2003;114(4):257–265.PubMedCrossRefGoogle Scholar
  15. 15.
    Han KR, Kim C, Eun JS, Chung YS. Extrapedicular approach of percutaneous vertebroplasty in the treatment of upper and mid-thoracic vertebral compression fracture. Acta Radiol 2005;46(3):280–287.PubMedGoogle Scholar
  16. 16.
    Komemushi A, Tanigawa N, Kariya S, Kojima H, Shomura Y, Sawada S. Percutaneous vertebroplasty for compression fracture: analysis of vertebral body volume by CT volumetry. Acta Radiol 2005;46(3):276–279.PubMedCrossRefGoogle Scholar
  17. 17.
    Lee ST, Chen JF. Closed reduction vertebroplasty for the treatment of osteoporotic vertebral compression fractures. Technical note. J Neurosurg 2004;100(4 suppl spine):392–396.PubMedGoogle Scholar
  18. 18.
    Martin JB, Jean B, Sugiu K, et al. Vertebroplasty: clinical experience and follow-up results. Bone (NY) 1999;25(2 suppl):11S–15S.PubMedCrossRefGoogle Scholar
  19. 19.
    Palussiere J, Berge J, Gangi A, et al. Clinical results of an open prospective study of a bis-GMA composite in percutaneous vertebral augmentation. Eur Spine J 2005;14:982–991.PubMedCrossRefGoogle Scholar
  20. 20.
    Phillips FM, Ho E, Campbell-Hupp M, McNally T, Todd Wetzel F, Gupta P. Early radiographic and clinical results of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Spine 2003;28(19):2260–2265; discussion 2265–2267.PubMedCrossRefGoogle Scholar
  21. 21.
    Winking M, Stahl JP, Oertel M, Schnettler R, Böker DK. Treatment of pain from osteoporotic vertebral collapse by percutaneous PMMA vertebroplasty. Acta Neurochir (Wien) 2004;146(5):469–476.CrossRefGoogle Scholar
  22. 22.
    Moreira-Gonzalez A, Jackson IT, Miyawaki T, Barakat K, DiNick V. Clinical outcome in cranioplasty: critical review in long-term follow-up. J Craniofac Surg 2003;14(2):144–153.PubMedCrossRefGoogle Scholar
  23. 23.
    Kiyoshige Y, Takagi M, Hamasaki M. Bone-cement fixation for calcaneus fracture: a report on 2 elderly patients. Acta Orthop Scand 1997;68(4):408–409.PubMedGoogle Scholar
  24. 24.
    Bohner M. Physical and chemical aspects of calcium phosphates used in spinal surgery. Eur Spine J 2001;10(suppl 2):S114–S121.PubMedGoogle Scholar
  25. 25.
    Ooms EM, Wolke JG, van der Waerden JP, Jansen JA. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 2002;61(1):9–18.PubMedCrossRefGoogle Scholar
  26. 26.
    Schildhauer TA, Bauer TW, Josten C, Muhr G. Open reduction and augmentation of internal fixation with an injectable skeletal cement for the treatment of complex calcaneal fractures. J Orthop Trauma 2000;14(5):309–317.PubMedCrossRefGoogle Scholar
  27. 27.
    Lobenhoffer P, Gerich T, Witte F, Tscherne H. Use of an injectable calcium phosphate bone cement in the treatment of tibial plateau fractures: a prospective study of twenty-six cases with twenty-month mean follow-up. J Orthop Trauma 2002;16(3):143–149.PubMedCrossRefGoogle Scholar
  28. 28.
    Cassidy C, Jupiter JB, Cohen M, et al. Norian SRS cement compared with conventional fixation in distal radial fractures. A randomized study. J Bone Joint Surg Am 2003;85A(11):2127–2137.Google Scholar
  29. 29.
    Sanchez-Sotelo J, Munuera L, Madero R. Treatment of fractures of the distal radius with a remodellable bone cement: a prospective, randomised study using Norian SRS. J Bone Joint Surg Br 2000;82(6):856–863.PubMedCrossRefGoogle Scholar
  30. 30.
    Verheggen R, Merten HA. Correction of skull defects using hydroxy apatite cement (HAC): evidence derived from animal experiments and clinical experience. Acta Neurochir (Wien) 2001;143(9):919–926.CrossRefGoogle Scholar
  31. 31.
    Goodman SB, Bauer TW, Carter D, et al. Norian SRS cement augmentation in hip fracture treatment. Laboratory and initial clinical results. Clin Orthop Relat Res 1998;348:42–50.PubMedCrossRefGoogle Scholar
  32. 32.
    Bai B, Jazrawi LM, Kummer FJ, Spivak JM. The use of an injectable, biodegradable calcium phosphate bone substitute for the prophylactic augmentation of osteoporotic vertebrae and the management of vertebral compression fractures. Spine 1999;24(15):1521–1526.PubMedCrossRefGoogle Scholar
  33. 33.
    Cho BC, Park JW, Baik BS, Kim IS. Clinical application of injectable calcium sulfate on early bony consolidation in distraction osteogenesis for the treatment of craniofacial microsomia. J Craniofac Surg 2002;13(3):465–475; discussion 475–477.PubMedCrossRefGoogle Scholar
  34. 34.
    Watson JT. The use of an injectable bone graft substitute in tibial metaphyseal fractures. Orthopedics 2004;27(1 suppl):s103–s107.PubMedGoogle Scholar
  35. 35.
    Kelly CM, Wilkins RM. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute. Orthopedics 2004;27(1 suppl):s131–s135.PubMedGoogle Scholar
  36. 36.
    Peterson B, Whang PG, Iglesias R, Wang JC, Lieberman JR. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. J Bone Joint Surg Am 2004;86A(10):2243–2250.Google Scholar
  37. 37.
    Thordarson DB, Kuehn S. Use of demineralized bone matrix in ankle/hindfoot fusion. Foot Ankle Int 2003;24(7):557–560.PubMedGoogle Scholar
  38. 38.
    Matsuda Y, Sakayama K, Okumura H, Kawatani Y, Mashima N, Shibata T. Percutaneous autologous bone marrow transplantation for nonunion of the femur. Nippon Geka Hokan 1998;67(1):10–17.PubMedGoogle Scholar
  39. 39.
    Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 1995;313:8–18.PubMedGoogle Scholar
  40. 40.
    Sideridou I, Tserki V, Papanastasiou G. Effect of chemical structure on degree of conversion in light-cured dimethacrylate-based dental resins. Biomaterials 2002;23(8):1819–1829.PubMedCrossRefGoogle Scholar
  41. 41.
    Pomrink GJ, DiCicco MP, Clineff TD, Erbe EM. Evaluation of the reaction kinetics of CORTOSS, a thermoset cortical bone void filler. Biomaterials 2003;24(6):1023–1031.PubMedCrossRefGoogle Scholar
  42. 42.
    Bauer TW, Smith ST. Bioactive materials in orthopaedic surgery: overview and regulatory considerations. Clin Orthop Relat Res 2002(395):11–22.PubMedCrossRefGoogle Scholar
  43. 43.
    Schwade ND. Wound adhesives, 2-octyl cyanoacrylate. 2005 (cited; available from: http://www.emedicine.com/ent/topic375. htm).Google Scholar
  44. 44.
    Ellman PI, Maxey PS, Tache-Leon C, et al. Evaluation of an absorbable cyanoacrylate adhesive as a suture line sealant. J Surg Res 2005;125:161–167.PubMedCrossRefGoogle Scholar
  45. 45.
    Axel Nitsch AP, Franz Honig J, Verheggen R, Merton H-A. Cellular, histomorphologic, and clinical characteristics of a new octyl-2-cyanoacrylate skin adhesive. Aesth Plastic Surg 2005;29:53–58.CrossRefGoogle Scholar
  46. 46.
    Hallock GG. Expanded applications for octyl-2-cyanoacrylate as a tissue adhesive. Ann Plast Surg 2001;46(2):185–189.PubMedCrossRefGoogle Scholar
  47. 47.
    Tseng YC, Hyon SH, Ikada Y, Shimizu Y, Tamura K, Hitomi S. In vivo evaluation of 2-cyanoacrylates as surgical adhesives. J Appl Biomater 1990;1(111):111–119.PubMedCrossRefGoogle Scholar
  48. 48.
    Falb RD. Adhesives in surgery. New Sci 1966:308–309.Google Scholar
  49. 49.
    Passage J, Tarn RK, Harrocks S, O’Brien MF. Bioglue surgical adhesive: an appraisal of its indications in cardiac surgery. Ann Thorac Surg 2002,74:432–437.PubMedCrossRefGoogle Scholar
  50. 50.
    Chao HH. BioGlue: albumin/glutaraldehyde sealant in cardiac surgery. J Cardiac Surg 2003;18:500–503.CrossRefGoogle Scholar
  51. 51.
    Hewitt CW, Kann BR, Tran HS, et al. Bioglue surgical adhesive for thoracic aortic repair during coagulopathy: efficacy and histopathology. Ann Thorac Surg 2001;71:1609–1612.PubMedCrossRefGoogle Scholar
  52. 52.
    Gundry SR, Izutani H. Sutureless coronary artery bypass with biologic glued anastomoses: preliminary in vivo and in vitro results. J Thorac Cardiovasc Surg 2000;120(3):473–477.PubMedCrossRefGoogle Scholar
  53. 53.
    Bavaria JE, Gorman RC, Woo YJ, Gleason T, Pochettino A. Advances in the treatment of acute type A dissection: an integrated approach. Ann Thorac Surg 2002;74(5):S1848–S1852; discussion S1857–S1863.PubMedCrossRefGoogle Scholar
  54. 54.
    Coselli JS, Fehrebacher J, Stowe CL, Macheers SK, Gundry SR. Prospective randomized study of a protein-based tissue adhesive used as a hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures. J Am Coll Surg 2003;197(2):243–252.PubMedCrossRefGoogle Scholar
  55. 55.
    Fink D, Kang H, Ergin MA. Application of biological glue in repair of intracradiac structural defects. Ann Thorac Surg 2004;77:506–511.PubMedCrossRefGoogle Scholar
  56. 56.
    Economopoulos GC, Brountzos E, Kelekis DA. Superior vena cava stenosis: a delayed Bioglue complication. J Thorac Cardiovasc Surg 2004;127(6):1819–1821.PubMedCrossRefGoogle Scholar
  57. 57.
    Porte HL, Akkad R, Conti M, Gillet PA, Guidat A, Wurtz AJ. Randomized controlled trial of a synthetic sealant for preventing alveolar air leaks after lobectomy. Ann Thorac Surg 2001;71:1618–1622.PubMedCrossRefGoogle Scholar
  58. 58.
    Torchiana DF. Polyethylene glycol based synthetic sealants:, potential uses in cardiac surgery. J Cardiac Surg 2003;18:504–506.CrossRefGoogle Scholar
  59. 59.
    Wallace DG, Rhee WM, Schroeder JA, et al. A tissue sealant based on reactive multifunctional polyethylene glycol. J Biomed Mater Res 2001;58:545–555.PubMedCrossRefGoogle Scholar
  60. 60.
    Stooker W, Jansen EK, Fritz J, et al. Surgical sealant in the prevention of early vein graft injury in an ex vivo model. Cardiovasc Pathol 2003;12:202–206.PubMedCrossRefGoogle Scholar
  61. 61.
    Wen DY. Intra-articular hyaluronic acid injections for knee osteoarthritis. Am Fam Physician 2000;62(3):565–570, 572.PubMedGoogle Scholar
  62. 62.
    Wain JC, Johnstone DW, Yang SC, et al. Trial of a novel synthetic sealant in preventing air leaks after lung resection. Ann Thorac Surg 2001;71:1623–1629.PubMedCrossRefGoogle Scholar
  63. 63.
    Glickman M, Money S, Martin J, Ballard JL. A polymeric sealant inhibits anastomotic suture hole bleeding more rapidly than gelfoam/thrombin: results of a randomized controlled trial. Arch Surg 2002;137(3):326–331;discussion 332.PubMedCrossRefGoogle Scholar
  64. 64.
    Hagberg RC, Sabik J, Conte J, Block JE. Improved intraoperative management of anastomotic bleeding during aortic reconstruction: results of a randomized controlled trial. Am Surg 2004;70(4):307–311.PubMedGoogle Scholar
  65. 65.
    Preul MC, Muench TR, Spetzler RF. Toward optimal tissue sealants for neurosurgery: use of a novel hydrogel sealant in a canine durotomy repair model. Neurosurgery 2003;53(5):1189–1198;discussion 1198–1199.PubMedCrossRefGoogle Scholar
  66. 66.
    Grotenhuis JA, Bartels RHMA, Beems T. A novel absorbable hydrogel for dural repair: results of a pilot clinical study. Department of Neurosurgery, University Medical Center, Nijmegen, St. Radboud Canisus Wilhelmina Hospital, Nijmegen Netherlands: 2005.Google Scholar
  67. 67.
    Ferland R, Campbell PK. Evaluation of a sprayable polyethylene glycol adhesion barrier in a porcine efficacy model. Hum Reprod 2001;16(12):2718–2723.PubMedCrossRefGoogle Scholar
  68. 68.
    Spotnitz WD. Commercial fibrin sealants in surgical care. Am J Surg 2001;182:8S–14S.PubMedCrossRefGoogle Scholar
  69. 69.
    Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg 2001;182:1S–7S.PubMedCrossRefGoogle Scholar
  70. 70.
    Saltz R, Sierra D, Feldman D, Saltz MB, Dimick A, Vasconez LO. Experimental and clinical applications of fibrin glue. Plastic Reconst Surg 1991;88:1005–1015.Google Scholar
  71. 71.
    Sidentop KH, Shah AN, Bhattacharyya TK, O’Grady KM. Safety and efficacy of currently available fibrin tissue adhesives. Am J Otolaryngol 2001;22(4):230–235.CrossRefGoogle Scholar
  72. 72.
    Rousou J, Levitsky S, Gonzalez-Lavin L, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. J Thorac Cardiac Surg 1989;97:194–203.Google Scholar
  73. 73.
    Matthew TL, Spotnitz WD, Kron IL, Daniel TM, Tribble CG, Nolan SP. Four years’ experience with fibrin sealant in thoracic and cardiovascular surgery. Ann Thorac Surg 1990;50:40–44.PubMedCrossRefGoogle Scholar
  74. 74.
    Schwartz M, Hirose R, Shaver TR, et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004;139:1148–1154.PubMedCrossRefGoogle Scholar
  75. 75.
    Rutgeerts P, Wara P, Swain P, et al. Randomised trial of single and repeated fibrin glue compared with injection of poidocaol in treatment of bleeding peptic ulcer. Lancet 1997;350:692–696.PubMedCrossRefGoogle Scholar
  76. 76.
    Hattori R, Otani H, Omiya H, et al. Fate of fibrin sealant in pericardial space. Ann Thorac Surg 2000;70:2132–2136.PubMedCrossRefGoogle Scholar
  77. 77.
    Mouritzen C, Keinecke HO. The effect of fibrin glueing to seal bronchial and alveolar leakages after pulmonary resections and decortications. Eur J Cardiothorac Surg 1993;7:75–80.PubMedCrossRefGoogle Scholar
  78. 78.
    Nguyen NT, Stevens M, Steward E, Paya M. The efficacy of fibrin sealant in prevention of anastomotic leak after laparoscopic gastric bypass. J Surg Res 2004;122:218–224.PubMedCrossRefGoogle Scholar
  79. 79.
    Suzuki Y, Kuroda Y, Morita A, et al. Fibrin glue sealing for the prevention of pancreatic fistulas following distal pancreatectomy. Arch Surg 1995;130:152–155.Google Scholar
  80. 80.
    Oz MC, Shargill NS. Floseal matrix: new generation topical hemostatic sealant. J Cardiac Surg 2003;18:486–493.CrossRefGoogle Scholar
  81. 81.
    MM Corporation. Zyderm Collagen Implant Physician Package Implant. 2000.Google Scholar
  82. 82.
    Alster TS, West TB. Fagien: human-derived and new synthetic injectable materials for soft-tissue augmentation: current status and role in cosmetic surgery. Plastic Reconst Surg 2000;105(7):2526–2528.CrossRefGoogle Scholar
  83. 83.
    Hotta TT. Dermal fillers. The next generation. Plastic Surg Nurs 2004;24(1):14–19.Google Scholar
  84. 84.
    Lemperle G, Morhenn V, Charrier U. Human histology and persistence of various injectable filler substances for soft tissue augmentation. Aesthet Plast Surg 2003;27(5):354–366;discussion 367.CrossRefGoogle Scholar
  85. 85.
    Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconst Surg 2005;115(1):282–289.PubMedGoogle Scholar
  86. 86.
    Carruthers A, Carey W, De Lorenzi C, Remington K, Schachter D, Sapra S. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds. Dermatol Surg 2005;31(11 pt 2):1591–1598.PubMedGoogle Scholar
  87. 87.
    I Corporation. CosmoDerm Human-Based Collagen Implant. 2003.Google Scholar
  88. 88.
    Sclafani AP, Romo T 3rd, Parker A, McCormick SA, Cocker R, Jacono A. Autologous collagen dispersion (Autologen) as a dermal filler: clinical observations and histologic findings. Arch Facial Plast Surg 2000;2(1):48–52.PubMedCrossRefGoogle Scholar
  89. 89.
    Kessels RR, Santanchè PP, Bonarrigo CC. Re: PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthet Plastic Surg 2000;24(1):73–75.Google Scholar
  90. 90.
    Breiting V, Aasted A, Jørgensen A, Opitz P, Rosetzsky A. A study on patients treated with polyacrylamide hydrogel injection for facial corrections. Aesthet Plastic Surg 2004;28(1):45–53.Google Scholar
  91. 91.
    Aasted, A. A prospective European multi-center study on 228 patients followed one year after facial correction with Aquamid. 2003.Google Scholar
  92. 92.
    Trevidic P. Prospective French multi-center study. 2003.Google Scholar
  93. 93.
    Freitas F. Prospective Brazilian multi-center study.Google Scholar
  94. 94.
    Tariki V. Lipodystrophy study, Brazil. 2003.Google Scholar
  95. 95.
    Santis D. Lipodystrophy study, Italy.Google Scholar
  96. 96.
    Clotet B. Lipodystrophy study, Spain.Google Scholar
  97. 97.
    Kanchwala. Reliable soft tissue augmentation: a clinical comparison of injectable soft-tissue fillers for facial-volume augmentation. Ann Plast Surg 2005;55(1):30–35.PubMedCrossRefGoogle Scholar
  98. 98.
    Comite SL, Liu JF, Balasubramanian S, Christian MA. Treatment of HIY-associated facial lipoatrophy with Radiance FN (Radiesse). Dermatology Online J 2004;10(2):2.Google Scholar
  99. 99.
    Davis JL, Serfass MS, Lai MY, Trask DK, Azen SP. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection. Arch Ophthalmol 1995;113(11):1401–1409.PubMedGoogle Scholar
  100. 100.
    Brourman ND, Blumenkranz MS, Cox MS, Trese MT. Silicone oil for the treatment of severe proliferative diabetic retinopathy. Ophthalmology 1989;96(6):759–764.PubMedGoogle Scholar
  101. 101.
    Aylward GW, Cooling RJ, Leaver PK. Trauma-induced retinal detachment associated with giant retinal tears. Retina 1993;13(2):136–141.PubMedCrossRefGoogle Scholar
  102. 102.
    Sell CH, McCuen BW 2nd, Landers MB 3rd, Machemer R. Long-term results of successful vitrectomy with silicone oil for advanced proliferative vitreoretinopathy. Am J Ophthalmol 1987;103(1):24–28.PubMedGoogle Scholar
  103. 103.
    Brinton GS, Aaberg TM, Reeser FH, Topping TM, Abrams GW. Surgical results in ocular trauma involving the posterior segment. Am J Ophthalmol 1982;93(3):271–278.PubMedGoogle Scholar
  104. 104.
    Silikon 1000 website, (cited: available from: www.silikon1000.com.)Google Scholar
  105. 105.
    Bausch & Lomb website, (cited: available from: http://www.bausch.com/us/resource/surgical/vitreo/adatostatement. jsp).Google Scholar
  106. 106.
    Bernal-Sprekelsen M, Caballero M, Farrè X, Calvo C, Alò L. Particulate silicone for vocal fold augmentation: morphometric evaluation in a rabbit model. Ann Otol Rhinol Laryngol 2004;113(3 pt 1):234–241.PubMedGoogle Scholar
  107. 107.
    Maas CS, Papel ID, Greene D, Stoker DA. Complications of injectable synthetic polymers in facial augmentation. Dermatol Surg 1997;23(10):871–877.PubMedCrossRefGoogle Scholar
  108. 108.
    Pollack SV. Silicone, fibrel, and collagen implantation for facial lines and wrinkles. J Dermatol Surg Oncol 1990;16(10):957–961.PubMedGoogle Scholar
  109. 109.
    Summary of Safety and Effectiveness Data for TRUFILL. FDA Review Application 2000;1–22.Google Scholar
  110. 110.
    N-Butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multicentertrial. AJNR Am J Neuroradiol 2002;23(5):748–755.Google Scholar
  111. 111.
    TRUFILL n-BCA Liquid Embolic System website, (cited: available from: http://www.jnjgateway.com/public/USENG/Endo-NeuroOct2003ProductCatalog.pdf).Google Scholar
  112. 112.
    Bayramoglu M, Karatas M, Cetin N, Akman N, Sözay S, Dilek A. Comparison of two different viscosupplements in knee osteoarthritis: a pilot study. Clin Rheumatol 2003;22(2):118–122.PubMedCrossRefGoogle Scholar
  113. 113.
    Lo GH, LaValley M, McAlindon T, Felson DT. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a metaanalysis. JAMA 2003;290(23):3115–3121.PubMedCrossRefGoogle Scholar
  114. 114.
    Kwon TK, Buckmire R. Injection laryngoplasty for management of unilateral vocal fold paralysis. Curr Opin Otolaryngol Head Neck Surg 2004;12(6):538–542.PubMedCrossRefGoogle Scholar
  115. 115.
    Fernandez-Acenero MJ, Zamora E, Borbujo J. Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 2003;29(12):1225–1226.PubMedCrossRefGoogle Scholar
  116. 116.
    Hyalgan. (cited: Available from: www.hyalgan.com.)Google Scholar
  117. 117.
    Synvisc. (cited: Available from: www.synvisc.com.)Google Scholar
  118. 118.
    Orthovisc. (cited: Available from: www.orthovisc.com.)Google Scholar
  119. 119.
    Supartz (cited: Available from: http://www.smithnephew.com/US/Standard.asp?NodeId=3242.)Google Scholar
  120. 120.
    Altman RD, Moskowitz R. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25(11):2203–2212.PubMedGoogle Scholar
  121. 121.
    Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 1994;37(4):521–528.PubMedCrossRefGoogle Scholar
  122. 122.
    George E. Intra-articular hyaluronan treatment for osteoarthritis. Ann Rheum Dis 1998;57(11):637–640.PubMedCrossRefGoogle Scholar
  123. 123.
    Sugiyama T, Hanai T, Hashimoto K, Umekawa T, Kurita T. Long-term outcome of the endoscopic correction of vesico-ureteric reflux: a comparison of injected substances. BJU Int 2004;94(3):381–383.PubMedCrossRefGoogle Scholar
  124. 124.
    Kumon H, Tsugawa M, Ozawa H, Monden K, Ohmori H. Endoscopic correction of vesicoureteral reflux by subureteric Teflon (polytetrafluoroethylene) injection: review of 6-year experience. Int J Urol 1997;4(6):541–545.PubMedCrossRefGoogle Scholar
  125. 125.
    Puri, Granata C. Multicenter survey of endoscopic treatment of vesicoureteral reflux using polytetrafluoroethylene. J Urol 1998;160(3 pt 2):1007–1011;discussion 1038.PubMedGoogle Scholar
  126. 126.
    Engel P, Palmer LS, Cheng EY, Kaplan WE. Surgical versus endoscopic correction of vesicoureteral reflux in children with neurogenic bladder dysfunction. J Urol 1997;157(6):2291–2294.PubMedCrossRefGoogle Scholar
  127. 127.
    Malizia AA Jr, Reiman HM, Myers RP, et al. Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 1984;251(24):3277–3281.PubMedCrossRefGoogle Scholar
  128. 128.
    Frey P, Lutz N, Jenny P, Herzog B. Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children. J Urol 1995;154(2 pt 2):804–807.PubMedGoogle Scholar
  129. 129.
    Steyaert H, Sattonnet C, Bloch C, Jaubert F, Galle P, Valla JS. Migration of PTFE paste particles to the kidney after treatment for vesico-ureteric reflux. BJU Int 2000;85(1):168–169.PubMedCrossRefGoogle Scholar
  130. 130.
    Adamsbaum C, Mascard E, Guinebretière JM, Kalifa G, Dubousset J. Intralesional Ethibloc injections in primary aneurysmal bone cysts: an efficient and safe treatment. Skeletal Radiol 2003;32(10):559–566.PubMedCrossRefGoogle Scholar
  131. 131.
    Cottalorda J, Kohler R, Chotel F. Recurrence of aneurysmal bone cysts in young children: a multicentre study. J Pediatr Orthop B 2005;14(3):212–218.PubMedGoogle Scholar
  132. 132.
    Krämer SC, Görich J, Rilinger N, et al. Embolization for gastrointestinal hemorrhages. Eur Radiol 2000;10(5):802–805.PubMedCrossRefGoogle Scholar
  133. 133.
    Dubois J, Chigot V, Grimard G, Isler M, Garel L. Sclerotherapy in aneurysmal bone cysts in children: a review of 17 cases. Pediatr Radiol 2003;33(6):365–372.PubMedGoogle Scholar
  134. 134.
    Guibaud L, Herbreteau D, Dubois J, et al. Aneurysmal bone cysts: percutaneous embolization with an alcoholic solution of zein: series of 18 cases. Radiology 1998;208(2):369–373.PubMedGoogle Scholar
  135. 135.
    Garg NK, Carty H, Walsh HP, Dorgan JC, Bruce CE. Percutaneous Ethibloc injection in aneurysmal bone cysts. Skeletal Radiol 2000;29(4):211–216.PubMedCrossRefGoogle Scholar
  136. 136.
    Summary of Safety and Effectiveness Data for Onyx. FDA Review Application 2003;1–39.Google Scholar
  137. 137.
    Louis H, Closset J, Deviere J. Enteryx. Best Pract Res Clin Gastroenterol 2004;18(1):49–59.PubMedCrossRefGoogle Scholar
  138. 138.
    Johnson DA, Ganz R, Aisenberg J, et al. Endoscopic implantation of enteryx for treatment of GERD: 12-month results of a prospective, multicenter trial. Am J Gastroenterol 2003;98(9):1921–1930.PubMedCrossRefGoogle Scholar
  139. 139.
    Molyneux AJ, Cekirge S, Saatci I, Gal G. Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers. AJNR Am J Neuroradiol 2004;25(1):39–51.PubMedGoogle Scholar
  140. 140.
    Johnson L, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg 2005;189:319–323.PubMedCrossRefGoogle Scholar
  141. 141.
    Sentovich SM. Fibrin glue for anal fistulas: long-term results. Dis Colon Rectum 2003;46(4):498–502.PubMedCrossRefGoogle Scholar
  142. 142.
    Sue B, Fingerhut A, Fourtanier G, et al. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intraabdominal complications after pancreatic resection. Ann Surg 2003;237(1):5765.Google Scholar
  143. 143.
    Lau H. Fibrin sealant versus mechanical stapling for mesh fixation during endoscopic extraperitoneal inguinal hernioplasty: a randomized prospective trial. Ann Surg 2005;242:670–675.PubMedCrossRefGoogle Scholar
  144. 144.
    Fabian T, Ponn RB. Fibrin glue in pulmonary resection: a prospective randomized, blinded study. Ann Thorac Surg 2003;75:1587–1592.PubMedCrossRefGoogle Scholar
  145. 145.
    Schenk WG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD. Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 2003;237(6):871–876.PubMedCrossRefGoogle Scholar
  146. 146.
    Levy BO, Martinowitz U, Oran A, Hashomer T, Tauber C, Horos-zowski H. The use of fibrin tissue adhesive to reduce blood loss and the need for blood transfusion after total knee arthroplasty: a prospective randomized multicenter study. J Bone Joint Surg 1999;81:1580–1588.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Bilal Shafi
    • 1
  • Carlos Mery
    • 2
  • Gary Binyamin
    • 3
  • Joseph Knight
    • 4
  • Michael E. Gertner
    • 3
  1. 1.Departments of Surgery and Cardiovascular MedicineStanford UniversityPalo AltoUSA
  2. 2.Department of SurgeryStanford UniversityMountain ViewUSA
  3. 3.Department of SurgeryStanford UniversityStanfordUSA
  4. 4.Department of Cardiovascular MedicineStanford UniversityStanfordUSA

Personalised recommendations